Cigna Corp. (NYSE:CI)‘s stock had its “buy” rating restated by Leerink Swann in a research note issued on Monday. They presently have a $155.00 target price on the stock. Leerink Swann’s price objective suggests a potential upside of 17.69% from the stock’s previous close.
A number of other analysts have also recently weighed in on CI. Barclays PLC increased their price objective on shares of Cigna Corp. from $156.00 to $168.00 and gave the stock an “equal weight” rating in a report on Wednesday, June 1st. Jefferies Group dropped their price objective on shares of Cigna Corp. from $160.00 to $153.00 and set a “buy” rating on the stock in a report on Monday, August 1st. Zacks Investment Research lowered shares of Cigna Corp. from a “buy” rating to a “hold” rating in a research report on Monday, July 11th. FBR & Co reiterated a “hold” rating on shares of Cigna Corp. in a research report on Monday, June 20th. Finally, Citigroup Inc. decreased their target price on shares of Cigna Corp. from $174.00 to $146.00 and set a “buy” rating for the company in a research report on Wednesday, August 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. Cigna Corp. has an average rating of “Buy” and a consensus price target of $157.65.
Cigna Corp. (NYSE:CI) opened at 131.70 on Monday. The stock has a 50 day moving average of $129.93 and a 200-day moving average of $132.06. The firm has a market cap of $33.79 billion, a price-to-earnings ratio of 17.08 and a beta of 0.54. Cigna Corp. has a 52-week low of $121.87 and a 52-week high of $148.99.
Cigna Corp. (NYSE:CI) last released its quarterly earnings data on Friday, July 29th. The company reported $1.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.39 by $0.41. Cigna Corp. had a return on equity of 17.60% and a net margin of 5.16%. The firm earned $9.89 billion during the quarter, compared to analyst estimates of $9.98 billion. During the same period last year, the business earned $2.55 EPS. The firm’s revenue was up 4.9% on a year-over-year basis. On average, analysts expect that Cigna Corp. will post $7.99 EPS for the current year.
In other news, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $132.28, for a total value of $66,140.00. Following the completion of the sale, the vice president now directly owns 4,017 shares of the company’s stock, valued at $531,368.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.20% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of CI. Marco Investment Management LLC raised its stake in Cigna Corp. by 0.6% in the second quarter. Marco Investment Management LLC now owns 1,585 shares of the company’s stock worth $203,000 after buying an additional 10 shares during the period. Checchi Capital Advisers LLC raised its stake in Cigna Corp. by 0.7% in the second quarter. Checchi Capital Advisers LLC now owns 2,624 shares of the company’s stock worth $336,000 after buying an additional 17 shares during the period. Synovus Financial Corp raised its stake in Cigna Corp. by 0.7% in the second quarter. Synovus Financial Corp now owns 3,285 shares of the company’s stock worth $420,000 after buying an additional 24 shares during the period. Mn Services Vermogensbeheer B.V. raised its stake in Cigna Corp. by 0.4% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 6,461 shares of the company’s stock worth $744,000 after buying an additional 24 shares during the period. Finally, Tdam USA Inc. raised its stake in Cigna Corp. by 1.2% in the second quarter. Tdam USA Inc. now owns 2,575 shares of the company’s stock worth $330,000 after buying an additional 30 shares during the period. 85.25% of the stock is owned by institutional investors and hedge funds.
Cigna Corp. Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.
Receive News & Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related companies with MarketBeat.com's FREE daily email newsletter.